Nurix Therapeutics, Inc. (NRIX) has a consensus analyst rating of Buy, based on 17 analysts covering the stock. Of those, 17 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for NRIX is $31.22, representing a +91.5% upside from the current price of $16.3. Price targets range from a low of $28.00 to a high of $36.00.
